Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | Dearborn Hts PO Box 600 MIAMI TX 48127-0600 |
Tel: | N/A |
Website: | https://drazcanna.com |
IR: | See website |
Key People | ||
Jihad Mohammad President, Chief Executive Officer, Director | Mouktar Makouk Chief Financial Officer, Treasurer | Pam Birtolo Chief Operating Officer |
Gerry L. Bedore Director - Technology Services | Timothy G. Drake Director - Technology Platforms |
Business Overview |
DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing. |
Financial Overview |
For the nine months ended 31 March 2016, Drazcanna Inc revenues decreased 9% to $1.5M. Net loss decreased 25% to $4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Impairment of Urban Planet assets decrease from $1.7M (expense) to $0K, Professional fees decrease of 36% to $724K (expense). |